Amicogen Inc (092040) — Cash Flow-to-Debt Ratio
Amicogen Inc (092040) has a Cash Flow-to-Debt Ratio of 0.01x as of December 2025, meaning its operating cash flow of ₩1.11 Billion could theoretically repay 0% of its total liabilities (₩136.00 Billion) in one year. See Amicogen Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Amicogen Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Amicogen Inc across 12 annual periods. Also explore 092040 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Amicogen Inc (2014–2025)
Year-by-year debt coverage analysis for Amicogen Inc. For market capitalisation and broader financial context, see 092040 market cap.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.18x | ₩-24.42 Billion | ₩136.00 Billion | ▼ -131.3% |
| 2024 | -0.08x | ₩-13.34 Billion | ₩171.73 Billion | ▼ -322.9% |
| 2023 | 0.03x | ₩8.64 Billion | ₩248.12 Billion | ▲ +146.3% |
| 2022 | -0.08x | ₩-22.41 Billion | ₩297.86 Billion | ▼ -309.8% |
| 2021 | 0.04x | ₩8.07 Billion | ₩225.06 Billion | ▼ -47.2% |
| 2020 | 0.07x | ₩8.87 Billion | ₩130.43 Billion | ▼ -7.4% |
| 2019 | 0.07x | ₩8.76 Billion | ₩119.35 Billion | ▲ +168.6% |
| 2018 | 0.03x | ₩2.84 Billion | ₩103.93 Billion | ▼ -82.9% |
| 2017 | 0.16x | ₩11.88 Billion | ₩74.32 Billion | ▼ -8.1% |
| 2016 | 0.17x | ₩11.28 Billion | ₩64.79 Billion | ▲ +9.6% |
| 2015 | 0.16x | ₩12.34 Billion | ₩77.74 Billion | ▼ -84.4% |
| 2014 | 1.02x | ₩4.43 Billion | ₩4.35 Billion | — |